scPharmaceuticals Inc.
General ticker "SCPH" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $191.4M (TTM average)
scPharmaceuticals Inc. follows the US Stock Market performance with the rate: 54.8%.
Estimated limits based on current volatility of 0.2%: low 5.66$, high 5.68$
Factors to consider:
- Total employees count: 164 (+21.5%) as of 2024
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.60$, 4.97$]
- 2025-12-31 to 2026-12-31 estimated range: [2.01$, 5.73$]
Financial Metrics affecting the SCPH estimates:
- Negative: with PPE of -2.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Shareholder equity ratio, % of 12.39 <= 19.77
- Negative: Operating cash flow per share per price, % of -46.72 <= 0.85
- Positive: Investing cash flow per share per price, % of 19.41 > -0.75
Short-term SCPH quotes
Long-term SCPH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $13.59MM | $36.33MM |
| Operating Expenses | $36.16MM | $68.99MM | $101.11MM |
| Operating Income | $-36.16MM | $-55.40MM | $-64.78MM |
| Non-Operating Income | $-0.68MM | $0.59MM | $-20.37MM |
| Interest Expense | $3.30MM | $8.12MM | $7.57MM |
| R&D Expense | $15.53MM | $11.81MM | $12.10MM |
| Income(Loss) | $-36.84MM | $-54.81MM | $-85.15MM |
| Profit(Loss)* | $-36.84MM | $-54.81MM | $-85.15MM |
| Stockholders Equity | $72.43MM | $37.22MM | $13.32MM |
| Inventory | $1.23MM | $8.84MM | $13.90MM |
| Assets | $124.19MM | $94.48MM | $107.52MM |
| Operating Cash Flow | $-34.58MM | $-59.24MM | $-70.54MM |
| Capital expenditure | $0.02MM | $0.04MM | $0.02MM |
| Investing Cash Flow | $-45.86MM | $19.96MM | $29.30MM |
| Financing Cash Flow | $77.23MM | $14.85MM | $70.08MM |
| Earnings Per Share** | $-1.30 | $-1.42 | $-1.91 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.